KALETRA ORAL SOLUTION Israel - inglés - Ministry of Health

kaletra oral solution

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

KALETRA ORAL SOLUTION Israel - inglés - Ministry of Health

kaletra oral solution

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Rosuvastatin Viatris 10 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

rosuvastatin viatris 10 mg film-coated tablets

viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin

Rosuvastatin Viatris 20 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

rosuvastatin viatris 20 mg film-coated tablets

viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin

Rosuvastatin Viatris 40 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

rosuvastatin viatris 40 mg film-coated tablets

viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin

Rosuvastatin Viatris 5 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

rosuvastatin viatris 5 mg film-coated tablets

viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin

Ethinylestradiol/Drospirenone Leon Farma & Placebo 0.02 mg/3 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ethinylestradiol/drospirenone leon farma & placebo 0.02 mg/3 mg film-coated tablets

laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.02/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

Ethinylestradiol/Drospirenone Leon Farma & Placebo 0.03 mg/3 mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ethinylestradiol/drospirenone leon farma & placebo 0.03 mg/3 mg film-coated tablets

laboratorios leon farma, s.a. - ethinylestradiol; drospirenone - film-coated tablet - 0.03/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

Hospira Vincristine Sulfate Injection USP 2 mg/2 mL vial Australia - inglés - Department of Health (Therapeutic Goods Administration)

hospira vincristine sulfate injection usp 2 mg/2 ml vial

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; mannitol; sodium hydroxide; sulfuric acid - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non-hodgkin's malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types), rhabdomyosarcoma, neuroblastoma, and wilm's tumor.